![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Avalo Therapeutics Inc is a clinical-stage precision medicine company that discovers, develops, and commercializes targeted therapeutics for patients with significant unmet clinical needs in immunology, immuno-oncology, and rare genetic diseases. Its pipeline consists of product candidates advancing... Avalo Therapeutics Inc is a clinical-stage precision medicine company that discovers, develops, and commercializes targeted therapeutics for patients with significant unmet clinical needs in immunology, immuno-oncology, and rare genetic diseases. Its pipeline consists of product candidates advancing in development with ongoing clinical programs: AVTX-002, AVTX-007, and AVTX-006. Show more
WAYNE, Pa. and ROCKVILLE, Md., June 24, 2024 (GLOBE NEWSWIRE) -- Avalo Therapeutics, Inc. (Nasdaq: AVTX) today announced that Paul Varki has joined the Company as its Chief Legal Officer. βWe...
WAYNE, Pa. and ROCKVILLE, Md., June 17, 2024 (GLOBE NEWSWIRE) -- Avalo Therapeutics, Inc. (Nasdaq: AVTX) announced today that Garry A. Neil, M.D., Chief Executive Officer and Chairman of the...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.76 | 6.7615658363 | 11.24 | 13.3 | 10.99 | 8929 | 12.74325587 | CS |
4 | 0.64 | 5.6338028169 | 11.36 | 14 | 10.3 | 14503 | 12.57594459 | CS |
12 | -1.62 | -11.8942731278 | 13.62 | 17.49 | 8.9174 | 36505 | 12.81021124 | CS |
26 | 4.49 | 59.7869507324 | 7.51 | 34.46 | 3.9501 | 355040 | 18.81172018 | CS |
52 | -73.2 | -85.9154929577 | 85.2 | 87.264 | 3.9501 | 23131090 | 32.0291143 | CS |
156 | -676.8 | -98.2578397213 | 688.8 | 1711.2 | 3.9501 | 8343287 | 39.31384809 | CS |
260 | -676.8 | -98.2578397213 | 688.8 | 1711.2 | 3.9501 | 8343287 | 39.31384809 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions